| DC Field | Value | Language |
|---|
| dc.contributor.author | Belousova, Ya. D. | - |
| dc.contributor.author | Kryukova, N. O. | - |
| dc.contributor.author | Filimonkina, Iu. A. | - |
| dc.contributor.author | Rafalskiy, V. V. | - |
| dc.date.accessioned | 2025-11-17T08:41:17Z | - |
| dc.date.available | 2025-11-17T08:41:17Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Pharmacoepidemiological analysis of drug therapy for asthenic syndrome as provided in Kaliningrad region / Belousova Ya.D., N.O. Kryukova, Filimonkina Iu.A., V.V. Rafalskiy // Research Results in Pharmacology. - 2025. - Vol.11, №3.-P. 37-43. - Doi: 10.18413/rrpharmacology.11.586. - Refer.: p. 42-43. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65884 | - |
| dc.description.abstract | Common medications were ethylmethylhydroxyperidine succinate (EMHPS) and combinations of inosine, nicotinamide, and riboflavin. The findings highlight inconsistent prescribing patterns and the need for standardized protocols to reduce polypharmacy and improve outcomes | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | asthenia | ru |
| dc.subject | pharmacotherapy | ru |
| dc.subject | drug therapy | ru |
| dc.subject | Kaliningrad region | ru |
| dc.title | Pharmacoepidemiological analysis of drug therapy for asthenic syndrome as provided in Kaliningrad region | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 3
|
